University of Adelaide, Adelaide, SA
Royal Adelaide Hospital, Adelaide, SA.
Med J Aust. 2017 Sep 2;207(7):309-315. doi: 10.5694/mja17.00457.
Irritable bowel syndrome (IBS) and other functional gastrointestinal disorders (FGIDs) are so prevalent they cannot reasonably have their diagnoses and management based within specialty care. However, delayed diagnosis, lengthy wait times for specialist review, overinvestigation and lack of clear diagnostic communication are common. The intrusive symptoms of IBS and other FGIDs impair patient functioning and reduce quality of life, and come with significant costs to individual patients and the health care system, which could be reduced with timely diagnosis and effective management. IBS, in particular, is no longer a diagnosis of exclusion, and there are now effective dietary and psychological therapies that may be accessed without specialist referral. The faecal calprotectin test is widely available, yet not on the Medical Benefits Schedule, and a normal test result reliably discriminates between people with IBS and patients who warrant specialist referral.
肠易激综合征（IBS）和其他功能性胃肠疾病（FGIDs）非常普遍，因此不能将其诊断和管理合理地局限在专科护理范围内。然而，延迟诊断、专科医生审查的长时间等待、过度检查以及缺乏明确的诊断沟通是常见的问题。IBS 和其他 FGIDs 的侵入性症状会影响患者的功能并降低生活质量，而且会给患者个人和医疗保健系统带来巨大的成本，这些成本可以通过及时诊断和有效管理来降低。特别是，IBS 不再是排除性诊断，现在有有效的饮食和心理疗法，可以在没有专科转介的情况下获得。粪便钙卫蛋白检测广泛可用，但不在医疗保险计划范围内，正常的检测结果可以可靠地区分 IBS 患者和需要专科转介的患者。
